The clinic offers financing options to help make the weight loss experience more accessible for everyone
The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists (dulaglutide, exenatide, liraglutide, semaglutide and tirzepatide) has been further updated to highlight the potential risk of severe acute pancreatitis with these products, including rare reports of necrotising and fatal pancreatitis
Feldman HA, et al
Previous reports have suggested that LMNA mutations can cause nuclear envelope instability, resulting in deformation and rupture of the nuclear envelope when muscle cell nuclei move outside during muscle fiber development
Gimnez-Palomo A, Guitart-Mampel M, Meseguer A, Borrs R, Garca-Garca FJ, Tobas E, et al
The story has been corrected